Mamdani, Vanderbilt Announce NYC Engineering Labs Deal

New York City

Mayor Zohran Kwame Mamdani and the New York City Economic Development Corporation (NYCEDC) today announced a $15.8 million capital commitment to Vanderbilt University to establish two advanced engineering research laboratories on Vanderbilt's Chelsea campus. NYCEDC's investment, matched by Vanderbilt, will establish the Visualization and Testing Environment for Medical Devices (VISE-MED) and the Vanderbilt Center for Intelligent Mobility (V-CITY), accelerating breakthroughs in surgical robotics, wearable technology, urban transit optimization and clean energy while expanding workforce development across the five boroughs.

As part of the investment, NYCEDC and the City will receive a share of revenue generated by intellectual property (IP) developed at VISE-MED and V-CITY. The agreement builds upon the Mamdani administration's historic, first-of-its-kind IP-sharing partnership with New York University's Quantum Fabrication Facility (QFab), announced last month.

"When the public invests in new technologies, the public should share in the returns," said Mayor Mamdani. "From wearable medical devices and advanced surgical robotics to clean energy infrastructure, these are the industries that will shape our future. We want to make sure they are built right here in New York City - creating good jobs and delivering benefits to the people who call this city home. We are proud to partner with Vanderbilt University on its first campus outside Nashville to bring this cutting-edge research and innovation to New York."

Under the agreement, the City will receive 50% of Vanderbilt's central administration share of the first $100,000 in annual revenue generated by each technology. For revenue above $100,000, the City will receive 27% of Vanderbilt's central administration share, in addition to a portion of school and department proceeds.

The agreement is designed to harness academic research to address complex municipal challenges while generating economic opportunities for New Yorkers. By securing a public share in the innovations created at these labs, the City will help ensure that publicly supported research returns to the communities that made it possible, rather than benefitting private interests alone.

The City has secured five seats, one-third of the total, on the labs' forthcoming advisory board, including dedicated representation for CUNY, City agency partners and labor representatives.

"We want New York at the forefront of the industries that will shape the future. These labs will be sites of innovation and discovery, stimulate good job creation, and promote economic growth," said Deputy Mayor for Economic Justice Julie Su. "And we will continue to demand that when NYC invests in something, New Yorkers get a real return on the investment through a share of revenue generated."

"The City's investment in Vanderbilt is an investment in New York's future: driving innovation, creating good jobs and preparing New Yorkers for the opportunities that follow," said NYCEDC President & CEO Anthony Shorris. "Not only will these labs bring cutting-edge research in surgical technology and urban mobility to New York City, but by securing a City share in the innovations created here, we're ensuring that the benefits of this investment return to the people of New York."

"Universities have an important role to play in helping cities address complex challenges," said Daniel Diermeier, chancellor of Vanderbilt University. "Our new home in New York City gives Vanderbilt an opportunity to bring our world-class research and expertise to bear on challenges that matter to New Yorkers, while opening new avenues for our faculty to pursue research and build partnerships in one of the world's greatest cities."

Vanderbilt is committing $16.2 million in operational and capital funding to establish the labs, with support from the chancellor, provost and Vanderbilt University School of Engineering. The investment will enable researchers to build teams, launch initial projects and engage local partners from the outset. Vanderbilt anticipates hiring 18 new staff members, including at least 12 faculty and research positions, to operate the facilities.

Both labs, housed within Vanderbilt's School of Engineering, are in design development phase and are expected to open in the first half of 2028. Together, they will create more than 200 jobs in New York City, train or upskill nearly 3,000 New Yorkers and provide more than 250 new internship opportunities.

VISE-MED: Bringing Surgical Innovation to Patient Care

Supported by a $12.1 million City capital award, VISE-MED will serve as an open-access engineering hub dedicated to designing, prototyping and validating surgical instruments, robotic platforms, wearable devices and mixed-reality systems for immersive medical visualization.

Beyond accelerating research and development, VISE-MED will strengthen New York City's medical technology ecosystem through four areas of focus: workforce development, next-generation talent pipelines, startup and venture support, and executive and leadership development. The facility will serve as an engine for career advancement and commercialization of new technologies.

VISE-MED will host 140 internships and give engineers and entrepreneurs hands-on experience in device prototyping, surgical robotics and wearable technology. It will also create training pathways for midcareer professionals and residents of the outer boroughs. The facility will offer discounted access for NYC-based and CUNY startups, as well as public and community hospitals seeking health care workforce training.

The lab will connect Vanderbilt researchers with New York City's deep pool of technical, health care and creative talent, while building partnerships with leading medical institutions, including Memorial Sloan Kettering Cancer Center and Hospital for Special Surgery . Rather than duplicating existing local efforts, VISE-MED will complement regional biodesign initiatives by helping translate clinical ideas into working technologies.

Over its first 10 years, VISE-MED is expected to support the formation or incubation of 10 to 15 new startups, serve 50 small businesses and establish 50 partnerships with industry and other organizations. It will also upskill more than 2,000 health care workers and train 650 executive leaders.

V-CITY: Tackling Urban Mobility and Grid Resilience

V-CITY, funded by a $3.7 million NYCEDC capital allocation, will focus on scalable technologies to reduce traffic congestion, improve public transit reliability and enhance energy grid stability. The lab will adapt and deploy intelligent mobility algorithms across New York's complex transit systems.

V-CITY will direct its efforts to support Next Stop: Fast Buses, Better Service, the City and State's July 2026 plan to make NYC buses faster and more reliable, and will optimize road, rail, and waterway use across New York City's multi-layered transportation network. Its central location in Chelsea will facilitate active coordination with municipal agencies and support nearly 50 public agency projects, giving university and civic partners a continuous place to test and deploy solutions that make an even greater difference in the daily lives of New Yorkers.

Working alongside local academic partners, community training centers and NYCEDC talent pipelines, the labs will connect New York City talent with Vanderbilt's Master of Science in Business and Technology program to support venture creation and workforce readiness.

Together, VISE-MED and V-CITY will advance research in surgical technology, urban mobility and clean energy while creating jobs, expanding career opportunities and delivering lasting economic and public benefit across the five boroughs. And through the City's revenue-sharing agreement, New Yorkers will have a stake in the innovations their public investment helps make possible.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.